Thus, imbalances in components of the intrarenal RAS, such as the up-regulation of AT1Rs in RCC cells and ACE in tumour vessels, have been associated with renal cancer development and progression [13,14,15]. The gene discussed is ACE; the disease is renal cell carcinoma.